cellbased

Scientists from Scripps Research and Cardiff University made key discoveries in support of a new stem cell-based therapy for Parkinson's disease. The approach, called an autologous therapy,…

Chicago, Jan. 25, 2023 (GLOBE NEWSWIRE) -- According to the new market research report "Cell-based Assays Market by Product & Service (Reagents, Microplate, Cell Lines, Assay Kits,…

-Total gross proceeds from transaction, before payment of transaction expenses, expected to be up to $82 million assuming no redemptions, combining a possible PIPE financing of up to $40…

GERMANTOWN, Md., Dec. 20, 2022 (GLOBE NEWSWIRE) -- Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global biotech company working to unlock the full potential of cell and…

New York, USA, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Treg Cell-based Therapies Pipeline Landscape Analysis of 22+ Companies by DelveInsight Given the various benefits offered, including…

NEW YORK, United States, Sept. 05, 2022 (GLOBE NEWSWIRE) -- According to Facts and Factors has published a new research report titled “Cell-based Assays Market Size, Share, Growth…

MONDAY, Aug. 22, 2022 (HealthDay News) -- The U.S. Food and Drug Administration has approved Zynteglo (betibeglogene autotemcel), the first cell-based gene therapy for the treatment of adult…

Cell-based therapies have long been thought of as an alternative treatment option for patients with a range of diseases caused by organ and tissue failure, inclusive of heart attack,…

Toronto, May 23 An islet cell transplant programme developed by a team of Canadian researchers is a safe, reliable and life-changing…

HOUSTON, May 04, 2022 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company specializing in the development of next-generation T…